Three common infections are associated with vaginal discharge: bacterial vaginosis, trichomoniasis and candidiasis, of which trichomoniasis is a sexually transmitted infection (STI). This guideline covers the presentation and clinical findings of these infections and outlines the differential diagnoses. Recommendations for investigation and management based on currently available evidence are made, including the management of persistent and recurrent infections.
AkinbiyiAA, WatsonR, Feyi-WabosoP. Prevalence of Candida albicans and bacterial vaginosis in asymptomatic pregnant women in South Yorkshire, United Kingdom. Outcome of a prospective study. Arch Gynecol Obstet2008;278:463–6
2.
OliveiraFA, PflegerV, LangK, Sexually transmitted infections, bacterial vaginosis, and candidiasis in women of reproductive age in rural Northeast Brazil: a population-based study. Mem Inst Oswaldo Cruz2007;102:751–6
3.
FangX, ZhouY, YangY, DiaoY, LiH. Prevalence and risk factors of trichomoniasis, bacterial vaginosis, and candidiasis for married women of child-bearing age in rural Shandong. Jpn J Infect Dis2007;60:257–61
4.
KoumansEH, SternbergM, BruceC, The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis2007;34:864–9
5.
BhallaP, ChawlaR, GargS, Prevalence of bacterial vaginosis among women in Delhi, India. Indian J Med Res2007;125:167–72
6.
DanM, KanetiN, LevinD, PochF, SamraZ. Vaginitis in a gynecologic practice in Israel: causes and risk factors. Isr Med Assoc J2003;5:629–32
7.
LamontRF, MorganDJ, WildenSD, Taylor-RobinsonD. Prevalence of bacterial vaginosis in women attending one of three general practices for routine cervical cytology. Int J STD AIDS2000;11:495–8.
8.
SchneiderH, CoetzeeDJ, FehlerHG, Screening for sexually transmitted diseases in rural South African women. Sex Transm Infect1998;74(Suppl 1):S147–52
9.
MarrazzoJM, AntonioM, AgnewK, HillierSL. Distribution of genital Lactobacillus strains shared by female sex partners. J Infect Dis2009;199:680–3
10.
SobelJD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann New York Acad Sci1988;544:547–57
11.
HollandJ, YoungML, LeeO, ChenS. Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect2003;79:249–50
12.
LindnerJG, PlantemaFH, HoogkampK. Quantitative studies of the vaginal flora of healthy women and of obstetric and gynaecological patients. J Med Microbiol1978;11:233–41
13.
OddsFC. Candida and Candidosis: A Review and Bibliography. 2nd edn.London: Bailliere Tindall, 1988.
14.
Wolner-HanssenP, KreigerJN, StevensCE, Clinical manifestations of vaginal trichomoniasis. JAMA1989;264:571–6
15.
FoutsAC, KrausSJ. Trichomonas vaginalis: re-evaluation of its clinical presentation and laboratory diagnosis. J Infect Dis1980;141:137–43
16.
LarssonPG, Platz-ChristensenJJ, ForsumU, PahlsonC. Clue cells in predicting infections after abdominal hysterectomy. Obstet Gynecol1991;77:450–2
17.
PerssonE, BergstromM, LarssonPG, Infections after hysterectomy. A prospective nation-wide Swedish study. The study group on infectious diseases in obstetrics and gynecology within the Swedish Society of obstetrics and gynecology. Acta Obstet Gynecol Scand1996;75:757–61
18.
SoperDE, BumpRC, HurtWG. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol1990;163:1016–21
19.
CharonisG, LarssonPG. Use of pH/whiff test or QuickVue Advanced pH and Amines test for the diagnosis of bacterial vaginosis and prevention of postabortion pelvic inflammatory disease. Acta Obstet Gynecol Scand2006;85:837–43
20.
LasseyAT, AdanuKR, NewmanMJ, OpintahJA. Potential pathogens in the lower genital tract at manual vacuum aspiration for incomplete abortion in Korle Bu Teaching Hospital, Ghana. East Afr Med J2004;81:398–401
21.
MillerL, ThomasK, HughesJP, Randomised treatment trial of bacterial vaginosis to prevent post-abortion complication. BJOG2004;111:982–8
22.
LarssonPG, Platz-ChristensenJJ, DalakerK, Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study. Acta Obstet Gynecol Scand2000;79:390–6
23.
LarssonPG, Platz-ChristensenJJ, ThejlsH, Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study. Am J Obstet Gynecol1992;166(1 Pt 1):100–3
24.
OakeshottP, HayP, HayS, Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks' gestation: prospective community based cohort study. BMJ2002;325:1334
25.
DondersGG, VanBB, CaudronJ, Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. Am J Obstet Gynecol2000;183:431–7
26.
Bacterial vaginosis increases the risk of first trimester miscarriage. BMJ1999;319:C
27.
RalphSG, RutherfordAJ, WilsonJD. Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ1999;319:220–3
28.
HayPE, LamontRF, Taylor-RobinsonD, MorganDJ, IsonC, PearsonJ. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ1994;308:295–8
29.
DondersGG, VanCK, BellenG, Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG2009;116:1315–24
30.
ThorpJMJr., DoleN, HerringAH, Alteration in vaginal microflora, douching prior to pregnancy, and preterm birth. Paediatr Perinat Epidemiol2008;22:530–7
31.
XuJ, HolzmanCB, ArvidsonCG, ChungH, GoepfertAR. Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery. Obstet Gynecol2008;112:524–31
32.
LeitichH, KissH. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol2007;21:375–90
SvareJA, SchmidtH, HansenBB, LoseG. Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections. BJOG2006;113:1419–25
35.
VogelI, ThorsenP, HoganVK, SchieveLA, JacobssonB, FerreCD. The joint effect of vaginal Ureaplasma urealyticum and bacterial vaginosis on adverse pregnancy outcomes. Acta Obstet Gynecol Scand2006;85:778–85
36.
GuerraB, GhiT, QuartaS, Pregnancy outcome after early detection of bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol2006;128:40–5
37.
GoyalR, SharmaP, KaurI, AggarwalN, TalwarV. Bacterial vaginosis and vaginal anaerobes in preterm labour. J Indian Med Assoc2004;102:548–50, 553
38.
RomeroR, ChaiworapongsaT, KuivaniemiH, TrompG. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol2004;190:1509–19
39.
LeitichH, Bodner-AdlerB, BrunbauerM, KaiderA, EgarterC, HussleinP. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol2003;189:139–47
40.
JacobssonB, PerneviP, ChidekelL, Platz-ChristensenJJ. Bacterial vaginosis in early pregnancy may predispose for preterm birth and postpartum endometritis. Acta Obstet Gynecol Scand2002;81:1006–10
41.
PurwarM, UghadeS, BhagatB, AgarwalV, KulkarniH. Bacterial vaginosis in early pregnancy and adverse pregnancy outcome. J Obstet Gynaecol Res2001;27:175–81
42.
McDonaldHM, O'LoughlinJA, JolleyPT, VigneswaranR, McDonaldPJ. Changes in vaginal flora during pregnancy and association with preterm birth. J Infect Dis1994;170:724–8
43.
GravettMG, HummelD, EschenbachDA, HolmesKK. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol1986;67:229–37
44.
ChohanVH, BaetenJ, BenkiS, A prospective study of risk factors for herpes simplex virus Type 2 Acquisition among high-risk HIV-1 Seronegative Kenyan Women. Sex Transm Infect2009;85:489–92
45.
AtashiliJ, PooleC, NdumbePM, AdimoraAA, SmithJS. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS2008;22:1493–501
46.
van de WijgertJH, MorrisonCS, CornelissePG, Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr2008;48:203–10
47.
GalloMF, WarnerL, MacalusoM, Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic. Sex Transm Dis2008;35:679–85
48.
PeipertJF, LapaneKL, AllsworthJE, ReddingCA, BlumeJD, SteinMD. Bacterial vaginosis, race, and sexually transmitted infections: does race modify the association?Sex Transm Dis2008;35:363–7
49.
KaulR, NagelkerkeNJ, KimaniJ, Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis2007;196:1692–7
50.
BrotmanRM, ErbeldingEJ, JamshidiRM, KlebanoffMA, ZenilmanJM, GhanemKG. Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics. J Pediatr Adolesc Gynecol2007;20:225–31
51.
NagotN, OuedraogoA, DeferMC, ValloR, MayaudP, Van de PerreP. Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies. Sex Transm Infect2007;83:365–8
52.
SchwebkeJR. Abnormal vaginal flora as a biological risk factor for acquisition of HIV infection and sexually transmitted diseases. J Infect Dis2005;192:1315–7
53.
CareyJC, KlebanoffMA, HauthJC, Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med2000;342:534–40
54.
KlebanoffMA, CareyJC, HauthJC, Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med2001;345:487–93
55.
OdendaalHJ, PopovI, SchoemanJ, Preterm labour – is bacterial vaginosis involved?. S Afr Med J2002;92:231–4
56.
GuiseJM, MahonSM, AickinM, Screening for bacterial vaginosis in pregnancy. Am J Prev Med2001;20 (3 Suppl):62–72
57.
MorencyAM, BujoldE. The effect of second-trimester antibiotic therapy on the rate of preterm birth. J Obstet Gynaecol Can2007;29:35–44
58.
Kurkinen-RatyM, VuopalaS, KoskelaM, A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. BJOG2000;107:1427–32
59.
GuaschinoS, RicciE, FranchiM, Treatment of asymptomatic bacterial vaginosis to prevent pre-term delivery: a randomised trial. Eur J Obstet Gynecol Reprod Biol2003;110:149–52
60.
JoesoefMR, HillierSL, WiknjosastroG, Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol1995;173:1527–31
61.
KekkiM, KurkiT, PelkonenJ, Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet Gynecol2001;97(5 Pt 1):643–8
62.
LamontRF, JonesBM, MandalD, The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy. Infect Dis Obstet Gynecol2003;11:181–9
63.
LarssonPG, FahraeusL, CarlssonB, Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen. BJOG2006;113:629–37
64.
UgwumaduA, ManyondaI, ReidF, HayP. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet2003;361:983–8
65.
SaurinaGR, McCormackWM. Trichomoniasis in pregnancy. Sex Trans Dis1997;24:361–2
66.
CotchMF, PastorekJG, NugentRP, Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Trans Dis1997;24:353–60
67.
KigoziGG, BrahmbhattH, Wabwire-MangenF, Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. Am J Obstet Gynecol2003;189:1398–400
68.
SorvilloF, KernottP. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet1998;351:213–4
69.
Van Der PolB, KwokC, Pierre-LouisB, Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis. 2008;197:548–54
70.
McClellandRS, SangareL, HassanWM, Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis. 2007;195:698–702
71.
SchaafVM, Perez-StableEJ, BorchardtK. The limited value of symptoms and signs in the diagnosis of vaginal infections. Arch Intern Med1990;150:1929–33
72.
AbbottJ. Clinical and microscopic diagnosis of vaginal yeast infection: a prospective analysis. Ann Emerg Med1995;25:587–91
73.
BergmanJJ, BergAO, SchneeweissR, HeidrichFE. Clinical comparison of microscopic and culture techniques in the diagnosis of Candida vaginitis. J Fam Pract1984;18:549–52
SonnexC, LefortW. Microscopic features of vaginal candidiasis and their relation to symptomatology. Sex Transm Infect1999;75:417–9
76.
ZdolsekB, HellbergD, FromanG, Culture and wet smear microscopy in the diagnosis of low-symptomatic vulvovaginal candidosis. Eur J Obstetr Gynecol Reprod Biol1995;58:47–51
77.
LandersDV, WiesenfeldHC, HeineRP, Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol2004;190:1004–10
78.
Platz-ChristensenJJ, LarssonPG, SundstromE, WiqvistN. Detection of bacterial vaginosis in wet mount, Papanicolaou stained vaginal smears and in Gram stained smears. Acta Obstet Gynecol Scand1995;74:67–70
79.
ThomasonJL, GelbartSM, AndersonRJ, Statistical evaluation of diagnostic criteria for bacterial vaginosis. Am J Obstet Gynecol1990;162:155–160
80.
AmselR, TottenPA, SpiegelCA, Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med1983;74:14–22
81.
IsonCA, HayPE. Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect2002;78:413–5
82.
NugentRP, KrohnMA, HillierSL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol1991;29:297–301
83.
DondersGG. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG2002;109:34–43
84.
HopwoodV, CrowleyT, HorrocksCT, Vaginal candidosis: relation between yeast counts and symptoms and clinical signs in non-pregnant women. Genitourin Med1988;64:331–4
85.
OddsFC, WebsterCE, RileyVC, FiskPG. Epidemiology of vaginal Candida infection: significance of numbers of vaginal yeasts and their biotypes. Eur J Obstetr Gynecol Reprod Biol1987;25:53–66
86.
OddsFC, WebsterCE, MayuranathanP, SimmonsPD. Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidosis. J Med Vet Mycol1988;26:277–83
87.
PriestleyCJ, JonesBM, DharJ, GoodwinL. What is normal vaginal flora?Genitourin Med1997;73:23–8
88.
BickleyLS, KrisherKK, PunsalangA, Comparison of direct fluorescent antibody, acridine orange, wet mount and culture for detection of Trichomonas vaginalis in women attending a public sexually transmitted disease clinic. Sex Trans Dis1989;16:127–31
89.
KreigerJN, TamMR, StevensCE, Diagnosis of trichomoniasis: comparison of conventional wet-mount examination with cytological studies, cultures, and monoclonal antibody staining of direct specimens. JAMA1988;259:1223–7
90.
KreigerJN, ViridansM, SiegelN, Risk assessment and laboratory diagnosis of trichomoniasis in men. J Infect Dis1992;166:1362–6
91.
SchmidGP, MathenyLC, ZaidiAA, Evaluation of six media for the growth of Trichomonas vaginalis from vaginal secretions. J. Clin. Microbiol1989;27:1230–3
92.
GelbartSM, ThomasonJL, OsypowskiPJ, Growth of Trichomonas vaginalis in commercial culture media. J Clin Microbiol1990;28:962–4
93.
MadicoG, QuinnTC, RompaloA, Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol1998;36:3205–10
94.
MaytaH, GilmanRH, CalderonMM, 18S ribosomal DNA-based PCR for the diagnosis of Trichomonas vaginalis. J Clin Microbiol2000;38:2683–7
95.
WeiseW, PatelSC, A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med2000;108:301–8
96.
CrucittiT, Van DyckE, TeheA, Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected swab specimens. Sex Transm Infect2003;79:393–8
PearlmanMD, YasharC, ErnstS, SolomonW. An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reactions to metronidazole. Am J Obstet Gynecol1996;174:934–6
99.
BistolettiP, FredricssonB, HagstromB, NordCE. Comparison of oral and vaginal metronidazole therapy for nonspecific bacterial vaginosis. Gynecol Obstet Invest1986;21:144–9
100.
OduyeboOO, AnorluRI, OgunsolaFT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev2009;CD006055
101.
SchindlerEM, ThammH, AnsmannEB, Treatment of bacterial vaginitis. Multicenter, randomized, open study with tinidazole in comparison with metronidazole. Fortschr Med1991;109:138–40
102.
VoorspoelsJ, CasteelsM, RemonJP, TemmermanM. Local treatment of bacterial vaginosis with a bioadhesive metronidazole tablet. Eur J Obstet Gynecol Reprod Biol2002;105:64–6
103.
HansonJM, McGregorJA, HillierSL, Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med2000;45:889–96
104.
BrandtM, AbelsC, MayT, Intravaginally applied metronidazole is as effective as orally applied in the treatment of bacterial vaginosis, but exhibits significantly less side effects. Eur J Obstet Gynecol Reprod Biol2008;141:158–62
105.
SchmittC, SobelJD, MeriwetherC. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol1992;79:1020–3
106.
AndresFJ, ParkerR, HoseinI, BenrubiGI. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: a prospective double-blind clinical trial. South Med J1992;85:1077–80
107.
FischbachF, PetersenEE, WeissenbacherER, Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol1993;82:405–10
108.
PaavonenJ, MangioniC, MartinMA, WajszczukCP. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet Gynecol2000;96:256–60
109.
FerrisDG, LitakerMS, WoodwardL, Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract1995;41:443–9
110.
MikamoH, KawazoeK, IzumiK, Comparative study on vaginal or oral treatment of bacterial vaginosis. Chemotherapy1997;43:60–8
111.
SchwebkeJR, DesmondRA. A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis2007;44:213–9
112.
MilaniM, BarcellonaE, AgnelloA. Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial. Eur J Obstet Gynecol Reprod Biol2003;109:67–71
113.
FornaF, GulmezogluAM. Interventions for treating trichomoniasis in women (Cochrane Review). In: The Cochrane Library. Issue 3, Oxford: Update Software, 2000
114.
HagerD, BrownST, KrausSJ, Metronidazole for vaginal trichomoniasis seven day vs single-dose regimens. JAMA1980;244:1219–20
115.
ThinRN, SymondsMAE, BookerR, Double-blind comparison of a single dose and a five-day course of metronidazole in the treatment of trichomoniasis. Brit J Vener Dis1979;55:354–6
116.
WatsonMC, GrimshawJM, BondCM, Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review. BJOG Int J Obstetr Gynaecol2002;109:85–95
117.
WatsonMC, GrimshawJM, BondCM, Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Update of Cochrane Database Syst Rev 2001;CD002845; 11279767. Cochrane Database of Syst Rev2001;4:CD002845
118.
BurtinP, TaddioA, AriburnuO, EinarsonTR, KorenG. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol1995;172:525–529
119.
CzeizelAE, RockenbauerM. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol1998;105:322–7
120.
Caro-PatonT, CarvajalA, de DiegoIM, Is metronidazole teratogenic: a meta-analysis. Br J Clin Pharmacol1997;44:179–82
121.
BisschopMP, MerkusJM, ScheygrondH, Van CutsemJ. Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study. Br J Obstetr Gynaecol1986;93:79–81.
122.
FongIW. The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole. Genitourin Med1992;68:174–6
123.
ColliE, LandoniM, ParazziniF. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourin Med1997;73:267–70
124.
LyngJ, ChristensenJ. A double blind study of treatment with a single dose tinidazole of partners to females with trichomoniasis. Acta Obstet Gynecol Scand1981;60:199–201
125.
DykersJR. Single dose metronidazole treatment for trichomonal vaginitis – patient and consort. N Eng J Med1975;293:23–4
126.
SobelJD, FerrisD, SchwebkeJ, Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol2006;194:1283–9
127.
LarssonPG, Stray-PedersenB, RyttigKR, LarsenS. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health2008;8:3
128.
MarconeV, CalzolariE, BertiniM. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. New Microbiol2008;31:429–33
129.
WilsonJD, ShannSM, BradySK, Recurrent bacterial vaginosis: the use of maintenance acidic vaginal gel following treatment. Int J STD AIDS2005;16:736–8
130.
SimoesJA, BahamondesLG, CamargoRP, A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br J Clin Pharmacol2006;61:211–7
131.
SpinilloA, PizzoliG, ColonnaL, Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis. Obstet Gynecol1993;81(5 (Pt 1):721–7
132.
DennersteinGJ. Depo-Provera in the treatment of recurrent vulvovaginal candidiasis. J Reprod Med1986;31:801–3
133.
SobelJ, WiesenfeldH, MartensM, Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. The New England Journal of Medicine2004;351:876–83
